Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
The altered pharmacokinetic properties of, e.g., aminoglycosides in cystic fibrosis patients have to be considered when pulmonary exacerbations are treated. Since reported data on ciprofloxacin, a fluorinated quinolone, are conflicting, we compared intravenous and oral administration in cystic fibro...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1992
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284363/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1489195/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.11.2512 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
